Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland · Delayed Price · Currency is CHF 10.82
-0.14 (-1.28%)
Sep 30, 2025, 5:31 PM CET
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of 215.98 million as of September 30, 2025. Its market cap has increased by 41.83% in one year.
Market Cap
215.98M
Enterprise Value
224.73M
Revenue
55.93M
Ranking
n/a
PE Ratio
9.73
Stock Price
10.82
Market Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 309.05M to 215.98M, a decrease of -30.11%. That is a compound annual growth rate of -1.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 215.98M | 24.01% |
| Dec 30, 2024 | 174.16M | 97.16% |
| Dec 29, 2023 | 88.33M | 219.35% |
| Dec 30, 2022 | 27.66M | -4.32% |
| Dec 30, 2021 | 28.91M | -24.65% |
| Dec 30, 2020 | 38.37M | -66.14% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 217.47B |
| Novartis AG | 190.49B |
| Lonza Group AG | 36.67B |
| Galderma Group AG | 32.14B |
| Alcon | 29.14B |
| Sandoz Group AG | 20.13B |
| Straumann Holding AG | 13.86B |
| Sonova Holding AG | 13.16B |